2 patents
Utility
ASGPR-binding compounds for the degradation of extracellular proteins
21 Nov 23
Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
Filed: 29 Jul 22
Utility
Asgpr-binding Compounds for the Degradation of Extracellular Proteins
30 Mar 23
Compounds and compositions that have an asialoglycoprotein receptor (ASGPR) binding ligand bound to an extracellular protein binding ligand for the selective degradation of the target extracellular protein in vivo to treat disorders mediated by the extracellular protein are described.
Mark George Saulnier, Jesse Jingyang Chen, Srinivasa Karra, Kevin Tyler Sprott, Jason Allan Wiles, Soumya Ray
Filed: 29 Jul 22
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first